HUGE.CNCNQHealthcare · Drug Manufacturers - Specialty & Generic

FSD Pharma Inc.

$0.13-13.79%($-0.02)

TickerSpark Score

45/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HUGE.CN research report →

52-Week Range0% of range

Low $0.13

Current $0.13

High $144.95

Companywww.fsdpharma.com

FSD Pharma Inc. , a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases.

CEO: Zeeshan Saeed
IPO: 2018
Employees: 17
HQ: Toronto, ON, CA

Price Chart

-95.28% · this period

Valuation

Market Cap: $88.58K
P/E: -0.15
P/S: 0.00
P/B: 0.27
EV/EBITDA: 0.10
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -108.36%
ROIC: -192.35%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-23,719,850 · -1.71%
EPS: $-0.60 · 0.00%
Op Income: $-25,484,066
FCF YoY: 62.27%

Performance & Tape

52W High: $144.95
52W Low: $0.13
50D MA: $11.34
200D MA: $50.39
Beta: 0.85
Avg Volume: 3.10K

Get TickerSpark's AI analysis on HUGE.CN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime